Viewing Study NCT04165967

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:44 AM
Ignite Modification Date: 2026-01-07 @ 8:08 AM
Study NCT ID: NCT04165967
Status: COMPLETED
Last Update Posted: 2024-04-10
First Post: 2019-11-05
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Adoptive Tumor-infiltrating Lymphocyte Transfer With Nivolumab for Melanoma
Sponsor: University Hospital, Basel, Switzerland
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Melanoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Tumor-infiltrating Lymphocyte (TIL) Transfer View
None Nivolumab View
None metastatic melanoma View
None anti-PD-1 therapy View
None failed immunotherapy View
None personalized Investigational Medicinal Product (IMP) View